US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

ARIA Opportunities ETF

25.70

-0.1332-0.52%

Volume:16

Turnover:439

Market Cap:12.42M

PE:- -

High:25.70

Open:25.83

Low:25.70

Close:25.83

52wk High:26.36

52wk Low:24.54

Shares:483.20K

Float Shares:483.20K

Volume Ratio:0.06

T/O Rate:0.00%

Dividend:- -

Dividend Rate:- -

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

LEQEMBI IQLIK® (lecanemab-irmb) Autoinjector for Initiation of Therapy Now Available in the U.S. for Early Alzheimer’s Disease

ProMIS Neurosciences to Host Webinar to Discuss Upcoming 6-Month Blinded Interim Data from PRECISE-AD Phase 1b Trial of PMN310 in Alzheimer’s Disease

FDA Approves LEQEMBI IQLIK® (lecanemab-irmb) Subcutaneous Injection as an Initiation Dose for Early Alzheimer’s Disease

Braiin Unveils AI Agent for Property Sector, Shares Soar Over 60%

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/stock/ARIA"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"ARIA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ARIA\",,,,,undefined,":{"symbol":"ARIA","market":"US","secType":"STK","nameCN":"ARIA Opportunities ETF","latestPrice":25.6967,"timestamp":1789502400000,"preClose":25.8299,"halted":0,"volume":16,"delay":0,"changeRate":-0.005156814389525265,"floatShares":483200,"shares":483200,"eps":0,"marketStatus":"Pre-Mkt","change":-0.1332,"latestTime":"09-16 04:10:13 EDT","open":25.8299,"high":25.6967,"low":25.6967,"amount":439,"amplitude":0,"askPrice":40.85,"askSize":100,"bidPrice":10.34,"bidSize":100,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1789565400000},"marketStatusCode":1,"adr":0,"exchange":"ARCA","adjPreClose":25.6967,"nav":25.82,"aum":12476015.93,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":25.8299,"preClose":25.6967,"latestTime":"16:10 EDT","volume":4,"amount":102.7868,"timestamp":1789503006909,"change":0.1332,"changeRate":0.005184,"amplitude":0},"volumeRatio":0.06289305209447228},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ARIA\",,,,,undefined,":{"symbol":"ARIA","floatShares":483200,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.06289305209447228,"shares":483200,"dividePrice":0,"high":25.6967,"amplitude":0,"preClose":25.8299,"low":25.6967,"week52Low":24.5362,"pbRate":"--","week52High":26.36,"institutionHeld":0.5771,"latestPrice":25.6967,"eps":0,"divideRate":0,"volume":16,"delay":0,"ttmEps":0,"open":25.8299,"prevYearClose":24.76,"prevWeekClose":26.0951,"prevMonthClose":25.4145,"prevQuarterClose":24.76,"fiveDayClose":25.9104,"twentyDayClose":25.5334},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ARIA\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ARIA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ARIA\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ARIA\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2661327966","title":"LEQEMBI IQLIK® (lecanemab-irmb) Autoinjector for Initiation of Therapy Now Available in the U.S. for Early Alzheimer’s Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2661327966","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661327966?lang=en_us&edition=fundamental","pubTime":"2026-08-24 20:04","pubTimestamp":1787573040,"startTime":"0","endTime":"0","summary":"LEQEMBI IQLIK is the first-of-its-kind anti-amyloid treatment worldwide offering at-home dosing for initiation and maintenance (approved in the U.S.)TOKYO and CAMBRIDGE, Mass., Aug.  24, 2026 (GLOBE N","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/24/3349698/0/en/leqembi-iqlik-lecanemab-irmb-autoinjector-for-initiation-of-therapy-now-available-in-the-u-s-for-early-alzheimer-s-disease.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARIA","BK4132","AD","MCI","CDR","BK4080","CAA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654236190","title":"ProMIS Neurosciences to Host Webinar to Discuss Upcoming 6-Month Blinded Interim Data from PRECISE-AD Phase 1b Trial of PMN310 in Alzheimer’s Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2654236190","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654236190?lang=en_us&edition=fundamental","pubTime":"2026-07-28 04:00","pubTimestamp":1785182400,"startTime":"0","endTime":"0","summary":"Cambridge, Massachusetts, July  27, 2026  (GLOBE NEWSWIRE) -- ProMIS Neurosciences Inc. (Nasdaq: PMN), a clinical-stage biotechnology company developing antibody therapeutics and vaccines targeting to","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/07/27/3333844/0/en/ProMIS-Neurosciences-to-Host-Webinar-to-Discuss-Upcoming-6-Month-Blinded-Interim-Data-from-PRECISE-AD-Phase-1b-Trial-of-PMN310-in-Alzheimer-s-Disease.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1815336091.USD","ARIA","BK4585","BK4023","LU0728928796.USD","LU0757428866.USD","BK4143","LU1169589451.USD","LU2125909916.SGD","BK4588","BK4218","LU2211815571.USD","BK4181","MSA","LU0154245673.USD","LU1169590202.USD","LU2125909759.SGD","HST","LU0053671581.USD","LU1923622291.USD","PD","BK4132","LU0154245756.USD","AD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651142696","title":"FDA Approves LEQEMBI IQLIK® (lecanemab-irmb) Subcutaneous Injection as an Initiation Dose for Early Alzheimer’s Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2651142696","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651142696?lang=en_us&edition=fundamental","pubTime":"2026-07-14 05:38","pubTimestamp":1783978680,"startTime":"0","endTime":"0","summary":"LEQEMBI IQLIK is a first-of-its-kind anti-amyloid treatment worldwide, offering at-home dosingfor initiation and maintenance (approved in the U.S.) U.S. launch of LEQEMBI IQLIK as an initiation dose p","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/07/13/3326503/0/en/FDA-Approves-LEQEMBI-IQLIK-lecanemab-irmb-Subcutaneous-Injection-as-an-Initiation-Dose-for-Early-Alzheimer-s-Disease.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MCI","BK4132","BK4588","CAA","BK4585","AD","LABU","ARIA","BK4080","CDR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1199098091","title":"Braiin Unveils AI Agent for Property Sector, Shares Soar Over 60%","url":"https://stock-news.laohu8.com/highlight/detail?id=1199098091","media":"Deep News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1199098091?lang=en_us&edition=fundamental","pubTime":"2026-07-14 03:00","pubTimestamp":1783969238,"startTime":"0","endTime":"0","summary":"Braiin Limited announced the launch of its new AI agent, ARIA, on Monday, marking its official entry into the property technology sector. The company's stock surged as much as 62% following the news,...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09979","159819","REET","BK1148","ARIA"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":3,"pageCount":1,"totalSize":9,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/ARIA\",params:#limit:6,delay:false,,,undefined,":[]}}